Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery

Macular DiseasesRetinal Diseases

Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection

Br J Ophthalmol.

Yoo JH, Ahn J, Oh J, Cha J, Kim SW

doi: 10.1136/

Risk of posterior capsule rupture during cataract surgery in eyes with previous intravitreal injections

Am J Ophthalmol.

Shalchi Z, Okada M, Whiting C, Hamilton R

doi: 10.1016/j.ajo.2017.02.006.

Surgery and Intervention

Association of Intravitreal Injections With Blood Pressure Increase: The Following Excitement and Anxiety Response Under Intravitreal Injection Study

JAMA Ophthalmol.

Berger V, Munk MR, Lersch F, Wolf S, Ebneter A, Zinkernagel MS

doi: 10.1001/jamaophthalmol.

Macular Diseases

Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis

Graefes Arch Clin Exp Ophthalmol.

Hanhart J, Comaneshter DS, Freier-Dror Y, Vinker S

doi: 10.1007/s00417-018-3917-9.

Glaucoma and Ocular PressureOcular Oncology

Comparison of Glaucoma Progression Between Unilateral and Bilateral Disc Hemorrhage Eyes and Associated Risk Factors for Progression

J Glaucoma.

Seol BR, Kim YK, Jeoung JW, Park KH

doi: 10.1097/

Glaucoma and Ocular PressureOcular OncologySurgery and Intervention

Genotype-Phenotype Associations of IL6 and PRG4 With Conjunctival Fibrosis After Glaucoma Surgery

JAMA Ophthalmol.

Yu-Wai-Man C, Tagalakis AD, Meng J, Bouremel Y, Lee RMH, Virasami A, Hart SL, Khaw PT

doi: 10.1001/jamaophthalmol.

Macular Diseases

Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema

Graefes Arch Clin Exp Ophthalmol.

Yu SY, Nam DH, Lee DY

doi: 10.1007/s00417-017-3819-2.

COMMENTED

Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France

JAMA Ophthalmol.

Baudin F, Benzenine E, Mariet AS, Bron AM, Daien V, Korobelnik JF, Quantin C, Creuzot-Garcher C

doi: 10.1001/

COMMENTED

Macular Diseases

Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration

JAMA Ophthalmol.

Dalvin LA, Starr MR, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Meissner I, Bakri SJ, Iezzi R

doi: 10.1001/jamaophthalmol.

Related content

Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection

Risk of posterior capsule rupture during cataract surgery in eyes with previous intravitreal injections

Association of Intravitreal Injections With Blood Pressure Increase: The Following Excitement and Anxiety Response Under Intravitreal Injection Study

Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis

Comparison of Glaucoma Progression Between Unilateral and Bilateral Disc Hemorrhage Eyes and Associated Risk Factors for Progression

Genotype-Phenotype Associations of IL6 and PRG4 With Conjunctival Fibrosis After Glaucoma Surgery

Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema

Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France

Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration